“Hypersensitivity Reactions Secondary to Dupilumab in Two Patients with Moderate to Severe Atopic Dermatitis” (2020) SKIN The Journal of Cutaneous Medicine, 4(4), pp. 372–374. doi:10.25251/skin.4.4.18.